Search
for
Sort by
Research 121–150 of 325
- PREVALENCE OF SKIN DISEASES IN A DERMATOLOGY OUTPATIENT CLINIC IN RIMS, KADAPA, A CROSS - SECTIONAL, RETROSPECTIVE STUDY
- Cutaneous lupus erythematosus
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies
- Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy
- Skin diseases in Turkish renal transplant recipients
- Prevalence of Skin Conditions Among Pediatric Patients in the Region of Istanbul
- Index of Suspicion
- Description of skin lesions
- Dermoscopy in General Dermatology: A Practical Overview
- Ex vivo detection of SARS CoV 2 spike protein in human hair follicles and potential link to telogen effluvium
- Secretome of Mesenchymal Stromal Cells as a Possible Innovative Therapeutic Tool in Facial Nerve Injury Treatment
- Refractory/relapse thrombocytopenia in a patient with Evans' syndrome successfully treated with zanubrutinib
- Severity grading of dermatological emergencies based on comorbidities and systemic involvement: An observational study
- Avian-Inspired Analogies in Dermatology
- Efficacy of Dupilumab in Treating Atopic Dermatitis With Recurrent Eczema Herpeticum in a Patient With DOCK8-Deficiency Hyper-IgE Syndrome: A Case Report
- Dermatologic Manifestations of Systemic Diseases in Childhood
- Skin diseases
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- The COVID-19 pandemic and its skin effects
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Floral Eponyms in Dermatology: A Blooming Collection of Patterns, Signs, and Appearances
- COVID‐19 and cutaneous manifestations: A review of the published literature
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- JAK inhibitors in dermatology: The promise of a new drug class
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- Vaccines, adjuvants and autoimmunity